[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2011048388A3 - Oral pharmaceutical and nutraceutical compositions - Google Patents

Oral pharmaceutical and nutraceutical compositions Download PDF

Info

Publication number
WO2011048388A3
WO2011048388A3 PCT/GB2010/001968 GB2010001968W WO2011048388A3 WO 2011048388 A3 WO2011048388 A3 WO 2011048388A3 GB 2010001968 W GB2010001968 W GB 2010001968W WO 2011048388 A3 WO2011048388 A3 WO 2011048388A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral pharmaceutical
nutraceutical compositions
nutraceutical
pharmaceutical
matrix
Prior art date
Application number
PCT/GB2010/001968
Other languages
French (fr)
Other versions
WO2011048388A2 (en
Inventor
Ingvild Johanne Haug
Kurt Ingvar Draget
Original Assignee
Probio Asa
Cockbain, Julian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probio Asa, Cockbain, Julian filed Critical Probio Asa
Publication of WO2011048388A2 publication Critical patent/WO2011048388A2/en
Publication of WO2011048388A3 publication Critical patent/WO2011048388A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention provides an oral pharmaceutical or nutraceutical composition comprising a pharmaceutical or nutraceutical agent disposed within a gelatin matrix, wherein said gelatin matrix further contains carrageenan at a content such that a 5mm thick sheet of said matrix would not dissolve within 4 hours at 37°C in an aqueous 0.1M HC1 solution containing 0.034 M NaC1.
PCT/GB2010/001968 2009-10-22 2010-10-22 Oral pharmaceutical and nutraceutical compositions WO2011048388A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0918590.1 2009-10-22
GB0918590A GB0918590D0 (en) 2009-10-22 2009-10-22 Composition

Publications (2)

Publication Number Publication Date
WO2011048388A2 WO2011048388A2 (en) 2011-04-28
WO2011048388A3 true WO2011048388A3 (en) 2011-06-30

Family

ID=41426585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/001968 WO2011048388A2 (en) 2009-10-22 2010-10-22 Oral pharmaceutical and nutraceutical compositions

Country Status (2)

Country Link
GB (1) GB0918590D0 (en)
WO (1) WO2011048388A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5878669B1 (en) * 2015-08-19 2016-03-08 三生医薬株式会社 Enteric capsule
JP7112409B2 (en) 2017-01-24 2022-08-03 ソシエテ・デ・プロデュイ・ネスレ・エス・アー Compositions Comprising Anti-Fel D1 Antibodies and Methods of Reducing At Least One Symptom of Cat Allergy in Humans
EP4427736A2 (en) * 2017-03-20 2024-09-11 Bayer HealthCare LLC Chewable gel products for active pharmaceutical ingredients

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033924A1 (en) * 1997-12-26 1999-07-08 Warner-Lambert Company Gelatine compositions
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
WO2004012701A2 (en) * 2002-08-02 2004-02-12 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
WO2007085840A1 (en) * 2006-01-25 2007-08-02 Probio Nutraceuticals As Emulsion
WO2009095670A1 (en) * 2008-01-29 2009-08-06 Ayanda As Soft gel capsules

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033924A1 (en) * 1997-12-26 1999-07-08 Warner-Lambert Company Gelatine compositions
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
WO2004012701A2 (en) * 2002-08-02 2004-02-12 Scitech Centre NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
WO2007085840A1 (en) * 2006-01-25 2007-08-02 Probio Nutraceuticals As Emulsion
WO2009095670A1 (en) * 2008-01-29 2009-08-06 Ayanda As Soft gel capsules

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HAUG I J ET AL: "Physical behaviour of fish gelatin-kappa-carrageenan mixtures", CARBOHYDRATE POLYMERS, APPLIED SCIENCE PUBLISHERS, LTD. BARKING, GB, vol. 56, no. 1, 17 May 2004 (2004-05-17), pages 11 - 19, XP004504327, ISSN: 0144-8617, DOI: DOI:10.1016/J.CARBPOL.2003.10.014 *
PRANOTO ET AL: "Characterizations of fish gelatin films added with gellan and kappa-carrageenan", LEBENSMITTEL WISSENSCHAFT UND TECHNOLOGIE, ACADEMIC PRESS, LONDON, GB, vol. 40, no. 5, 22 February 2007 (2007-02-22), pages 766 - 774, XP005931403, ISSN: 0023-6438, DOI: DOI:10.1016/J.LWT.2006.04.005 *

Also Published As

Publication number Publication date
WO2011048388A2 (en) 2011-04-28
GB0918590D0 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
IL250937A0 (en) Pharmaceutical compositions and kits containing an acid sphingomyelinase
ZA201101097B (en) Pharmaceutical composition of n-[2,4-bis (1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and administration thereof
IL192925A0 (en) 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
EP2172225A8 (en) Seamless capsule
AP2416A (en) Stabilized pharmaceutical compositions comprising fesoterodine.
WO2011067667A3 (en) Fexofenadine microcapsules and compositions containing them
BRPI0814687A2 (en) IN VITRO METHOD TO INHIBIT A MEMBER OF THE RHO GTPASE FAMILY, COMPOUND, AND PHARMACEUTICAL COMPOSITION.
WO2010069532A8 (en) Antibodies against human angiopoietin 2
IL193776A0 (en) A pharmaceutical composition containing an aminosalicylate active agent
HK1126667A1 (en) Self preserved aqueous pharmaceutical compositions
IL199835A (en) Acid activated antimicrobial peptides, pharmaceutical compositions comprising the same and use thereof for the preparation of medicaments
AP2006003844A0 (en) Orodispersible pharmaceutical composition for oromucosal or sublingual administration of agomelatine
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
WO2010123999A3 (en) 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor
IL202235A (en) 2-phenylethylaminoacetic acid amides and thioamides, derivatives thereof and pharmaceutical compositions comprising the same
WO2011128627A8 (en) Oral veterinary pharmaceutical and nutraceutical compositions
WO2011048388A3 (en) Oral pharmaceutical and nutraceutical compositions
SI1886686T1 (en) Pharmaceutical composition containing mometasone furoate
PL2266619T3 (en) Pharmaceutical composition based on hepatoprotector and prebiotic, the production and use thereof
EP2233467A4 (en) Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof
ZA201101669B (en) Pharmaceutical combination comprising 6-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3 diol and paracetamol
ZA200905440B (en) Pharmaceutical composition containing phloroglucinol and paracetamol
WO2011017346A3 (en) Fast-acting naproxen composition with reduced gastrointestinal effects
WO2011128631A3 (en) Vegetarian oral pharmaceutical and nutraceutical compositions
UA102010C2 (en) Combination of active ingredients comprising a non steroidal anti inflammatory drug and a colchicoside derivative

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10771805

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10771805

Country of ref document: EP

Kind code of ref document: A2